Live feed
·
INSIDERFilingvia Quantisnow
HashiCorp Inc. logo

HashiCorp (HCP) CTO Dadgar sold 35,904 shares for $1.21M at $33.71 under a 10b5-1 plan

ByQuantisnow·Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Armon Dadgar (Chief Technology Officer at HashiCorp Inc., HCP) reported that they sold 35,904 shares for $1.21M at $33.71, and acquired 35,904 shares on Aug 2, 2024. After these transactions the filing shows 1,520,000 shares held indirectly (See footnote).

Reporting person
Dadgar Armon
Role
CHIEF TECHNOLOGY OFFICER
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Aug 2, 2024Conversion of a derivative (C)Class A Common Stock1, 2+35,904--1,555,904 indirect
Aug 2, 2024Open-market sale (S)Class A Common Stock2, 3, 4-35,904$33.71$1.21M1,520,000 indirect

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Aug 2, 2024Conversion of a derivative (C)Class B Common StockOn 35,904 Class A Common Stock1, 2-35,904--12,338,892 indirect

Holdings before and after

  • Class B Common Stock: 12,374,796 to 12,338,892 indirect, See footnote

Other positions listed

  • Class A Common Stock: 23,234 direct
  • Class A Common Stock: 282,617 indirect, See footnote
  • Class A Common Stock: 90,440 indirect, See footnote

Footnotes from the filing

  1. 1. Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.
  2. 2. The shares are held of record by the Armon Dadgar 2020 Charitable Trust.
  3. 3. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 7, 2023.
  4. 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.64 to $33.79, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  5. 5. The shares are held of record by the Armon Memaran-Dadgar Living Trust for which the reporting person serves as trustee.
  6. 6. The shares are held of record by Black Swan III, LLC which the reporting person controls.

Transaction codes in this filing

Open-market sale:
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Conversion of a derivative:
Code C marks the conversion of a derivative, such as preferred stock or units, into another security.

FAQ

What did Dadgar report in this HCP Form 4?

Armon Dadgar (Chief Technology Officer at HashiCorp Inc., HCP) reported that they sold 35,904 shares for $1.21M at $33.71, and acquired 35,904 shares on Aug 2, 2024. After these transactions the filing shows 1,520,000 shares held indirectly (See footnote).

How many HCP shares does Dadgar hold after this filing?

The filing shows 1,520,000 shares held indirectly (See footnote) after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

Was this HCP insider sale made under a 10b5-1 plan?

The filing's footnotes mention a Rule 10b5-1 trading plan. Such a plan sets the terms of future trades in advance.

What does transaction code S mean on an SEC Form 4?

Code S marks a sale in the open market or a private deal. The insider received cash for these securities.

Historical context for HCP

Earlier insider filings at HCP

Quantisnow market dataNASDAQ
HashiCorp Inc. logo
HCP
HashiCorp Inc.
Market cap
30-day
Sector
Technology
Industry
EDP Services
Listed since
2021
Get push alerts for HCP

Follow HCP and get a push notification the moment its next story breaks.

Full HCP profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HCP (HashiCorp Inc.) and more on Quantisnow.